Summary.-Ovarian function was studied in 18 female patients treated for abdominal tumours during childhood. All received abdominal radiotherapy as part of their treatment and were studied between 1 and 26 years after irradiation. The serum gonadotrophins and oestradiol levels were consistent with ovarian failure in each case but there was a disproportionate elevation in serum follicle stimulating hormone (FSH) when compared to serum luteinizing hormone (LH) in 16. In 2 patients, the radiotherapeutic field extended downwards only as far as the sacral promontory. However, these 2 girls show similar evidence of ovarian failure to that in the other 16.
RADIOTHERAPY is an accepted method of inducing an artificial menopause. Doll and Smith (1968) found that 9700 of 2068 women failed to menstruate again after an estimated ovarian dose of 360-720 rad given in 1, 2 or 3 fractions. There is, however, a paucity of data concerning ovarian function following abdominal irradiation in childhood. Pearson, Duncan and Pointon (1964) observed 3 out of 5 girls who, having received abdominal irradiation for nephroblastoma, later presented with primary amenorrhoea. Unfortunately no endocrine data were available in these cases. We therefore decided to examine ovarian function in patients who had received irradiation for abdominal lesions during childhood.
PATIENTS AND METHODS
Eighteen female patients who, in childhood, had received treatment for abdominal lesions, were studied. There were 13 cases of nephroblastoma, 3 of neuroblastoma, 1 of rhabdomyosarcoma bladder and 1 of reticulo-endothelial disease of uncertain histology. All 18 had abdominal surgery and irradiation, and 7 had chemotherapy. Only 2 patients (subjects No. 7 and 9) were still receiving cytotoxic agents at the time of the study. The dose of abdominal irradiation ranged from 2000-3000 rad over 25-44 days. In 16 cases the whole abdomen, including the pelvis, was irradiated. In 2 cases (subjects No. 7 and 12), however, the radiation zone was restricted to above the level of the sacral promontory.
Serum FSH and LH levels were measured by double antibody radioimmunoassay using Medical Research Council standard 69/104. Serum oestradiol was measured by radioimmunoassay as published elsewhere (England et al., 1974 (Siegel, 1956 Mean concentration for serum oestradiol in adult women (luteal phase): 67-3 ± 1-47 (se mean) pg/ml.
RESULTS
The mean age at menarche in the United Kingdom is 13-4years (Marshall and Tanner, 1969 phamide are known to cause amenorrhoea (Kumar et al., 1972) and, in some instances, ovarian fibrosis (Millar, Williams and Leissring, 1971 ). However, only 1 girl in this group received cyclophosphamide and only 2 girls were currently being treated with chemotherapeutic agents at the time of the study. There is no difference between the endocrine profile in these girls and the rest of the group not treated with drugs.
In these 18 patients, the probable cause of the ovarian failure is abdominal irradiation, with chemotherapy potentially an additional factor in a minority.
The serum FSH level was raised in all 18 patients whilst the serum LH level was raised in 15. Furthermore, the serum FSH shows a more marked elevation than the serum LH in 16 patients, with the data in the remaining 2 patients not sufficiently detailed to allow this distinction to be detected.
This disproportionate elevation of serum FSH as compared to serum LH is similar to that described in gonadal dysgenesis (Penny et al., 1970) . This suggests that despite marked differences in the pathogenesis of ovarian failure, the qualitative gonadotrophin response is identical.
Conte, Grumbach and Kaplan (1975) observed a sharp increase of serum gonadotrophin levels in patients with gonadal dysgenesis from the age of 11 years, while Job et al. (1974) noted similar findings from the age of 12 years. We can only provide further data on the serum LH changes, which show a similar increase from the age of 11 years onwards. This confirms that the pattern of gonadotrophin regulation changes at around the age of 11-12 years in girls with ovarian failure, just as is seen in normal subjects.
Ovarian failure following abdominal irradiation is not always a permanent defect. Baker et al. (1972) described one woman who received pelvic irradiation for Hodgkin's disease followed by 2 years' amenorrhoea, then irregular menstruation, and finally the birth of a u normal child 6 years later. Consequently we were encouraged to learn that subject No. 3 had her first period 4 months after our tests had confirmed ovarian failure. However, she has had no subsequent periods for 3 months and continues to have very high basal gonadotrophins and low serum oestradiol levels. Sherman and Korenman (1975) observed similar hormonal patterns in perimenopausal women, many of whom had irregular,. anovulatory cycles, and presumably the isolated period of subject No. 3 represented a similar phenomenon. Our patients were studied between 1 and 26 years after irradiation and there must be very little hope of ovarian recovery in the majority of them.
The main pathological diagnosis in this group of patients was nephroblastoma, which represents approximately 8% of all childhood malignancy (Ledlie et al., 1970) . There has been a considerable improvement in the cure rate of this tumour after the addition of cyclic chemotherapy to surgery and irradiation. Thus, the 2-year cure rate, for patients who presented with localized abdominal disease, has risen to 80%.
As abdominal irradiation is used by some in the management of the various stages of this disease, results should be assessed with reference to the sequelae detailed in this paper. It should be noted that our 2 patients (subjects No. 7 and 12) who received abdominal irradiation with a field which extended down only as far as the sacral promontory show a similar hormonal pattern of ovarian failure to that seen in the other 16 cases. This suggests that if ovarian function is to be preserved then the lower limit of the radiation field will need to be raised.
